The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intra-Uterine Contraceptive Devices Market Research Report 2025
Synopsis
Intra-Uterine Contraceptive Devices are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices. An Intra-Uterine Contraceptive Device is a T-shaped device, made of flexible plastic, with a copper wire wrapped around its stem, and is considered a safe and reliable method of sterilization for women. It is inserted into the uterus, and its primary aim is to prevent the fertilization of the egg by causing changes.
The global Intra-Uterine Contraceptive Devices market was valued at US$ 2134 million in 2023 and is anticipated to reach US$ 2474.2 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The major factors for the growth of the intra-uterine contraceptive devices market include the technological innovations leading to effective contraception and fewer side effects, increasing rate of unintended pregnancies, etc. Over the past few years, the awareness of contraception has contributed to both the decline in unplanned pregnancies and the growth of the contraception market. Family planning efforts, which include increasing access to intrauterine contraceptive devices, can help reduce unintended pregnancies. The use of intra-uterine contraceptive devices decreased the proportion of births that were unplanned. The usage of intra-uterine contraceptive devices is increasing year on year as women find intra-uterine contraceptive devices the most convenient, safe, and effective form of contraception.
This report aims to provide a comprehensive presentation of the global market for Intra-Uterine Contraceptive Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intra-Uterine Contraceptive Devices.
Report Scope
The Intra-Uterine Contraceptive Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intra-Uterine Contraceptive Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intra-Uterine Contraceptive Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Yantai JiShengYaoXie
Tianyi Medical Equipment
Merck
Cooper Companies
AbbVie Allergan
SMB Corporation of India
H & J Medical
HRA Pharma
Eurogine
Segment by Type
Copper IUCD
Hormonal IUCD
Segment by Application
Hospitals
Gynaecology Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intra-Uterine Contraceptive Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intra-Uterine Contraceptive Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intra-Uterine Contraceptive Devices are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices. An Intra-Uterine Contraceptive Device is a T-shaped device, made of flexible plastic, with a copper wire wrapped around its stem, and is considered a safe and reliable method of sterilization for women. It is inserted into the uterus, and its primary aim is to prevent the fertilization of the egg by causing changes.
The global Intra-Uterine Contraceptive Devices market was valued at US$ 2134 million in 2023 and is anticipated to reach US$ 2474.2 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The major factors for the growth of the intra-uterine contraceptive devices market include the technological innovations leading to effective contraception and fewer side effects, increasing rate of unintended pregnancies, etc. Over the past few years, the awareness of contraception has contributed to both the decline in unplanned pregnancies and the growth of the contraception market. Family planning efforts, which include increasing access to intrauterine contraceptive devices, can help reduce unintended pregnancies. The use of intra-uterine contraceptive devices decreased the proportion of births that were unplanned. The usage of intra-uterine contraceptive devices is increasing year on year as women find intra-uterine contraceptive devices the most convenient, safe, and effective form of contraception.
This report aims to provide a comprehensive presentation of the global market for Intra-Uterine Contraceptive Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intra-Uterine Contraceptive Devices.
Report Scope
The Intra-Uterine Contraceptive Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intra-Uterine Contraceptive Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intra-Uterine Contraceptive Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
Yantai JiShengYaoXie
Tianyi Medical Equipment
Merck
Cooper Companies
AbbVie Allergan
SMB Corporation of India
H & J Medical
HRA Pharma
Eurogine
Segment by Type
Copper IUCD
Hormonal IUCD
Segment by Application
Hospitals
Gynaecology Clinics
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intra-Uterine Contraceptive Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intra-Uterine Contraceptive Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intra-Uterine Contraceptive Devices Market Overview
1.1 Product Overview and Scope of Intra-Uterine Contraceptive Devices
1.2 Intra-Uterine Contraceptive Devices Segment by Type
1.2.1 Global Intra-Uterine Contraceptive Devices Market Value Comparison by Type (2024-2030)
1.2.2 Copper IUCD
1.2.3 Hormonal IUCD
1.3 Intra-Uterine Contraceptive Devices Segment by Application
1.3.1 Global Intra-Uterine Contraceptive Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Gynaecology Clinics
1.4 Global Intra-Uterine Contraceptive Devices Market Size Estimates and Forecasts
1.4.1 Global Intra-Uterine Contraceptive Devices Revenue 2019-2030
1.4.2 Global Intra-Uterine Contraceptive Devices Sales 2019-2030
1.4.3 Global Intra-Uterine Contraceptive Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intra-Uterine Contraceptive Devices Market Competition by Manufacturers
2.1 Global Intra-Uterine Contraceptive Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intra-Uterine Contraceptive Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intra-Uterine Contraceptive Devices Average Price by Manufacturers (2019-2024)
2.4 Global Intra-Uterine Contraceptive Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intra-Uterine Contraceptive Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intra-Uterine Contraceptive Devices, Product Type & Application
2.7 Intra-Uterine Contraceptive Devices Market Competitive Situation and Trends
2.7.1 Intra-Uterine Contraceptive Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intra-Uterine Contraceptive Devices Players Market Share by Revenue
2.7.3 Global Intra-Uterine Contraceptive Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intra-Uterine Contraceptive Devices Retrospective Market Scenario by Region
3.1 Global Intra-Uterine Contraceptive Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intra-Uterine Contraceptive Devices Global Intra-Uterine Contraceptive Devices Sales by Region: 2019-2030
3.2.1 Global Intra-Uterine Contraceptive Devices Sales by Region: 2019-2024
3.2.2 Global Intra-Uterine Contraceptive Devices Sales by Region: 2025-2030
3.3 Global Intra-Uterine Contraceptive Devices Global Intra-Uterine Contraceptive Devices Revenue by Region: 2019-2030
3.3.1 Global Intra-Uterine Contraceptive Devices Revenue by Region: 2019-2024
3.3.2 Global Intra-Uterine Contraceptive Devices Revenue by Region: 2025-2030
3.4 North America Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
3.4.1 North America Intra-Uterine Contraceptive Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intra-Uterine Contraceptive Devices Sales by Country (2019-2030)
3.4.3 North America Intra-Uterine Contraceptive Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
3.5.1 Europe Intra-Uterine Contraceptive Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intra-Uterine Contraceptive Devices Sales by Country (2019-2030)
3.5.3 Europe Intra-Uterine Contraceptive Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Intra-Uterine Contraceptive Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intra-Uterine Contraceptive Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Intra-Uterine Contraceptive Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
3.7.1 Latin America Intra-Uterine Contraceptive Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intra-Uterine Contraceptive Devices Sales by Country (2019-2030)
3.7.3 Latin America Intra-Uterine Contraceptive Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intra-Uterine Contraceptive Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Intra-Uterine Contraceptive Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intra-Uterine Contraceptive Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intra-Uterine Contraceptive Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Intra-Uterine Contraceptive Devices Sales by Type (2019-2030)
4.1.1 Global Intra-Uterine Contraceptive Devices Sales by Type (2019-2024)
4.1.2 Global Intra-Uterine Contraceptive Devices Sales by Type (2025-2030)
4.1.3 Global Intra-Uterine Contraceptive Devices Sales Market Share by Type (2019-2030)
4.2 Global Intra-Uterine Contraceptive Devices Revenue by Type (2019-2030)
4.2.1 Global Intra-Uterine Contraceptive Devices Revenue by Type (2019-2024)
4.2.2 Global Intra-Uterine Contraceptive Devices Revenue by Type (2025-2030)
4.2.3 Global Intra-Uterine Contraceptive Devices Revenue Market Share by Type (2019-2030)
4.3 Global Intra-Uterine Contraceptive Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intra-Uterine Contraceptive Devices Sales by Application (2019-2030)
5.1.1 Global Intra-Uterine Contraceptive Devices Sales by Application (2019-2024)
5.1.2 Global Intra-Uterine Contraceptive Devices Sales by Application (2025-2030)
5.1.3 Global Intra-Uterine Contraceptive Devices Sales Market Share by Application (2019-2030)
5.2 Global Intra-Uterine Contraceptive Devices Revenue by Application (2019-2030)
5.2.1 Global Intra-Uterine Contraceptive Devices Revenue by Application (2019-2024)
5.2.2 Global Intra-Uterine Contraceptive Devices Revenue by Application (2025-2030)
5.2.3 Global Intra-Uterine Contraceptive Devices Revenue Market Share by Application (2019-2030)
5.3 Global Intra-Uterine Contraceptive Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bayer Intra-Uterine Contraceptive Devices Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Yantai JiShengYaoXie
6.2.1 Yantai JiShengYaoXie Corporation Information
6.2.2 Yantai JiShengYaoXie Description and Business Overview
6.2.3 Yantai JiShengYaoXie Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yantai JiShengYaoXie Intra-Uterine Contraceptive Devices Product Portfolio
6.2.5 Yantai JiShengYaoXie Recent Developments/Updates
6.3 Tianyi Medical Equipment
6.3.1 Tianyi Medical Equipment Corporation Information
6.3.2 Tianyi Medical Equipment Description and Business Overview
6.3.3 Tianyi Medical Equipment Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tianyi Medical Equipment Intra-Uterine Contraceptive Devices Product Portfolio
6.3.5 Tianyi Medical Equipment Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Intra-Uterine Contraceptive Devices Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Cooper Companies
6.5.1 Cooper Companies Corporation Information
6.5.2 Cooper Companies Description and Business Overview
6.5.3 Cooper Companies Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cooper Companies Intra-Uterine Contraceptive Devices Product Portfolio
6.5.5 Cooper Companies Recent Developments/Updates
6.6 AbbVie Allergan
6.6.1 AbbVie Allergan Corporation Information
6.6.2 AbbVie Allergan Description and Business Overview
6.6.3 AbbVie Allergan Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AbbVie Allergan Intra-Uterine Contraceptive Devices Product Portfolio
6.6.5 AbbVie Allergan Recent Developments/Updates
6.7 SMB Corporation of India
6.6.1 SMB Corporation of India Corporation Information
6.6.2 SMB Corporation of India Description and Business Overview
6.6.3 SMB Corporation of India Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SMB Corporation of India Intra-Uterine Contraceptive Devices Product Portfolio
6.7.5 SMB Corporation of India Recent Developments/Updates
6.8 H & J Medical
6.8.1 H & J Medical Corporation Information
6.8.2 H & J Medical Description and Business Overview
6.8.3 H & J Medical Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 H & J Medical Intra-Uterine Contraceptive Devices Product Portfolio
6.8.5 H & J Medical Recent Developments/Updates
6.9 HRA Pharma
6.9.1 HRA Pharma Corporation Information
6.9.2 HRA Pharma Description and Business Overview
6.9.3 HRA Pharma Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 HRA Pharma Intra-Uterine Contraceptive Devices Product Portfolio
6.9.5 HRA Pharma Recent Developments/Updates
6.10 Eurogine
6.10.1 Eurogine Corporation Information
6.10.2 Eurogine Description and Business Overview
6.10.3 Eurogine Intra-Uterine Contraceptive Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Eurogine Intra-Uterine Contraceptive Devices Product Portfolio
6.10.5 Eurogine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intra-Uterine Contraceptive Devices Industry Chain Analysis
7.2 Intra-Uterine Contraceptive Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intra-Uterine Contraceptive Devices Production Mode & Process
7.4 Intra-Uterine Contraceptive Devices Sales and Marketing
7.4.1 Intra-Uterine Contraceptive Devices Sales Channels
7.4.2 Intra-Uterine Contraceptive Devices Distributors
7.5 Intra-Uterine Contraceptive Devices Customers
8 Intra-Uterine Contraceptive Devices Market Dynamics
8.1 Intra-Uterine Contraceptive Devices Industry Trends
8.2 Intra-Uterine Contraceptive Devices Market Drivers
8.3 Intra-Uterine Contraceptive Devices Market Challenges
8.4 Intra-Uterine Contraceptive Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
